Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung injury with high mortality; no approved medication exists. Efficacy and safety of bone marrow–derived, allogeneic, multipotent adult progenitor cells (invimestrocel) plus standard treatment in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichikado, Kazuya, Kotani, Toru, Kondoh, Yasuhiro, Imanaka, Hideaki, Johkoh, Takeshi, Fujimoto, Kiminori, Nunomiya, Shin, Kawayama, Tomotaka, Sawada, Masanori, Jenkins, Eric, Tasaka, Sadatomo, Hashimoto, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464414/
https://www.ncbi.nlm.nih.gov/pubmed/37608287
http://dx.doi.org/10.1186/s13287-023-03451-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464414/
https://www.ncbi.nlm.nih.gov/pubmed/37608287
http://dx.doi.org/10.1186/s13287-023-03451-z

Ejemplares similares